An exploration of biosimilar TNF-alpha inhibitors uptake determinants in hospital environments in Italy, Portugal, and Spain

BACKGROUND: The availability of biosimilar medicines in Southern European markets has allowed purchasing biologics at a lower cost for healthcare systems. However, the capacity to seize this cost-reduction opportunity in the long run depends on fostering a sustainable competitive environment for all...

Descripción completa

Detalles Bibliográficos
Autores principales: Barcina Lacosta, Teresa, Vulto, Arnold G., Huys, Isabelle, Simoens, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871571/
https://www.ncbi.nlm.nih.gov/pubmed/36703896
http://dx.doi.org/10.3389/fmed.2022.1029040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871571/
https://www.ncbi.nlm.nih.gov/pubmed/36703896
http://dx.doi.org/10.3389/fmed.2022.1029040

Ejemplares similares